Apellis Pharmaceuticals (APLS) Q3 2024 Earnings

Aug 1Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.17
-0.88
-0.59
-0.3

Details

Expected EPS
-0.306225
Actual EPS
-0.3
Surprise EPS
0.01
Surprise Percent
+2.03%

Description

⁨Apellis Pharmaceuticals⁩ (⁦APLS⁩) has reported earnings of ⁦-0.3⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts